[1]
|
I. Brondz, D. Mantzeilas, U. Klein, M. N. Lebedeva, F. S. Mikhailitsyn, G. D. Souleimanov and D. Ekeberg, “The Main Contaminant of the Antimalarial Drug Primaquine Is Its Positional Isomer,” 3rd International Symposium on Separation in BioSciences SBS 2003 A 100 Years of Chromatography, Abstract P-57, 13-18 May 2003, Moscow, Russia, p. 165.
|
[2]
|
I. Brondz, D. Mantzilas, U. Klein, D. Ekeberg, E. Hvattum, M. N. Lebedeva, F. S. Mikhailitsyn, G. D. Souleimanov and J. R?e, “Nature of the Main Contaminant in the Antimalarial Drug Primaquine Diphosphate: A Qualitative Isomer Analysis,” Journal of Chromatography B, Vol. 800, No. 1-2, 2004, pp. 211-223.
doi:10.1016/j.jchromb.2003.09.042
|
[3]
|
I. Brondz, U. Klein, D. Ekeberg, D. Mantzilas, E. Hvattum, H. Schultz and F. S. Mik-hailitsyn, “Nature of the Main Contaminant in the Drug Prima-quine Diphosphate: GC-MS Analysis,” Asian Journal of Che-mistry, Vol. 17, No. 3, 2005, pp. 1678-1688.
|
[4]
|
V. G. Don-gre, P. P. Karmuse, M. M. Nimbalkar, D. Singh and A. Kumar, “Applications of GC-EI-MS for the Identification and Investigation of Positional Isomer in Primaquine, an Antimalarial Drug,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 39, No. 1-2, 2005, pp. 111-116. doi:10.1016/j.jpba.2005.03.019
|
[5]
|
I. Brondz, “SFC-MS Analysis of Contaminants in Primaquine Diphosphate Tablets and Spectral UV and NMR Characterizing of Primaquine and Quinocide,” In: E. Csizmadia and I. Kalnoky, Eds., Antimalarial Drugs: Costs, Safety and Efficacy, Chapter 5, Nova Science Publishers, Inc., New York, 2009, pp. 105-124.
|
[6]
|
I. Brondz, “Historical Overview of Chromatography and Related Techniques in Analysis of Antimalarial Drug Primaquine,” In: T. J. Quintin, Ed., Chromatography: Types, Techniques and Methods, Chapter 6, Nova Science Publishers, Inc., New York, 2010, pp. 281-322.
|
[7]
|
I. Brondz, “Historical Overview of Chromatography and Related Techniques,” In: I. Brondz, Ed., Analysis of Antimalarial Drug Primaquine, Nova Science Publishers, Inc., New York, 2011.
|
[8]
|
R. C. Elderfield, W. J. Gensler, J. D. Head, H. A. Hageman, C. B. Kremer, J. B. Wright, A. D. Holley, B. Williamson, J. Galbreath, L. Wiel-derhold III, R. Frohardt, S. M. Kupchan, T. A. Williamson and O. Birstein, “Alkylaminoalkyl Derivatives of 8-Aminoquinoline1,” Journal of the American Chemical Society, Vol. 68, No. 8, 1946, pp. 1524-1528. doi:10.1021/ja01212a040
|
[9]
|
S. P. Singh, S. S. Parmar and V. I. Stenberg, “Carbon-13 Nuclear Magnetic Resonance Spectra of Potent Antimalarials: Primaquine and Chloroquine,” Journal of Heterocyclic Chemistry, Vol. 15, No. 1, 1978, pp. 9-11.
doi:10.1002/jhet.5570150102
|
[10]
|
A. M. Clark, C. D. Hufford and J. D. McChesney, “Primaquine: Metabolism by Microor-ganisms and 13C Nuclear Magnetic Resonance Assignments,” Antimicrobial Agents and Chemotherapy, Vol. 19, No. 2, 1981, pp. 337- 341.
|